NCT05322824

Brief Summary

Through prospective registration and follow-up, this study will collect data of patients with intracranial/carotid stenosis, including clinical information, neuropsychological scales, multimodal magnetic resonance images. The investigators aim to analyze clinical and imaging characteristics of patients with cognitive impairment related to intracranial/carotid stenosis, in order to achieve early identification of cognitive impairment.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
43mo left

Started Jan 2022

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress56%
Jan 2022Dec 2029

Study Start

First participant enrolled

January 1, 2022

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

April 1, 2022

Completed
11 days until next milestone

First Posted

Study publicly available on registry

April 12, 2022

Completed
5.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2029

Last Updated

April 18, 2023

Status Verified

March 1, 2023

Enrollment Period

6 years

First QC Date

April 1, 2022

Last Update Submit

April 16, 2023

Conditions

Keywords

Cognitive FunctionIntracranial / Carotid Stenosis

Outcome Measures

Primary Outcomes (1)

  • Changes in the scores of Mini-mental State Examination

    Total score of 30. Higher scores mean a better outcome.

    2 years

Secondary Outcomes (10)

  • Incidence of stroke event including ischemic and hemorrhagic stroke

    2 years

  • Changes in cerebral glymphatic function

    2 years

  • Changes in the scores of Montreal Cognitive Assessment

    2 years

  • Changes in cerebral blood flow in the territory of the culprit artery

    2 years

  • Changes in the scores of Colour Trail Test

    2 years

  • +5 more secondary outcomes

Interventions

standard medical treatment

Interventional stenting

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with intracranial / carotid stenosis aged ≥ 40 years

You may qualify if:

  • Patients aged ≥ 40 years
  • ≥ 50% stenosis in unilateral intracranial / carotid artery
  • Written informed consent available

You may not qualify if:

  • Previous history of major head trauma and any intracranial surgery
  • Intracranial abnormalities, such as intracerebral hemorrhage, subarachnoid hemorrhage and other space occupying lesions
  • Extrapyramidal symptoms or mental illness which may affect neuropsychological measurement
  • Severe loss of vision, hearing, or communicative ability
  • Exit Criteria:
  • For any poor adherence, not comply with the requirements of the follow-up, or safety reasons determined by investigator
  • Any adverse or serious adverse events during the study period judged by investigator

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Second Affilated Hospital of Zhejiang University, School of Medicine

Hangzhou, Zhejiang, 310009, China

RECRUITING

MeSH Terms

Conditions

Constriction, PathologicCarotid Stenosis

Condition Hierarchy (Ancestors)

Pathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsCarotid Artery DiseasesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesArterial Occlusive DiseasesVascular DiseasesCardiovascular Diseases

Central Study Contacts

Min Lou, PhD, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 1, 2022

First Posted

April 12, 2022

Study Start

January 1, 2022

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2029

Last Updated

April 18, 2023

Record last verified: 2023-03

Locations